BIIB
Biogen (BIIB)
NASDAQ
$223.10+$3.22 (+1.46%)
Price as of Oct 02, 2026 7:46 PM EDT
  • $32.9B
    Market Cap
  • 37.53%
    1-Year Change
  • Drug Manufacturers - General
    Industry

Earnings Score

Score: 41
Valuation
BIIB
vs History
vs S&P 500
Profitability
-0
Growth
-1
Low Earnings Volatility
0

Momentum Score

Score: 62
Valuation
BIIB
vs History
vs S&P 500
3-Month Momentum
6.16%
12-Month Momentum
43.43%
3-Month Risk Adjusted Momentum
36.89%
12-Month Risk Adjusted Momentum
131.82%

True Yield

N/A
Valuation
BIIB
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
-4.06%

Financial Health Score

Score: 16
Valuation
BIIB
vs History
vs S&P 500
Ohlson's O-Score
8